Skip to main content
University of Pittsburgh
  • Find People
  • Other Link
Center for Pharmaceutical Policy and Prescribing
  • About
  • People
    • Featured Faculty
    • Opportunities
  • News
    • Newsletters
  • Events
  • Publications
    • Drug Pricing and Cost Publications
    • Opioids Publications
    • Past Publications
    • Pharmacoepidemiology Publications
    • Pharmacoequity Publications
    • Viewpoints
  • Research
  • CP3 Hosts First Pharmacoequity Conference

    Save the Date! on May 20, CP3 will host the first-ever Pharmacoequity Conference, with Keynote Speaker Dr. Jasmine Marcelin and research and policy panels. Register here!

    CP3 Events Page
  • Pitt Awarded $3.5M to Improve Disparities in Insulin Access

    The University of PIttsburgh has been awarded an unprecedented $3.5M from The Leona M. and Harry B. Helmsley Charitable Trust to study effectiveness of long-acting analogue insulin in children and young people with Type 1 diabetes. CP3 Faculty Affiliate Dr. Jing Luo will be the study PI. This work addresses disparities in insulin access for kids in resource-poor areas and will lead to improved insulin access globally.

    Read more about the grant
  • Donohue Study Stresses Need to Change Opioid Prescribing

    Findings from a multi-disciplinary opioid prescriptions study led by Health Policy and Management Chair Dr. Julie Donohue point to need to change opioid-prescribing practices in key patient-care settings.

    Learn more about Dr. Donohue’s study here
  • Photo of Dr. Suda

    Suda Receives Excellence in Government Award

    CP3 Associate Director Dr. Katie Suda was awarded the Excellence in Government Silver Award for Outstanding Contributions to Science (Medical). The award was bestowed by the Pittsburgh Federal Executive Board for Dr. Suda's work at the Pittsburgh VA and the VA's Center for Health Equity Research and Promotion.

    Read more about Dr. Suda's work here

Improving the Quality, Safety and Efficiency of Medication Use

While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.

Dr. Gellad and Dr. Moyo working together at a desk
Work with us
Featured faculty
Dr. Gellad, Dr. Frank, and Dr. Donohue
Events

Home

News

View All News
Med Reviews for Paxlovid Prescribing a Must, Says Gellad
TTS Rare But Serious Side Effect, Gellad Tells Politico
Paxlovid Distribution Has Barriers, Gellad Tells NYT
Health Affairs Paper Co-Authored by CP3 Faculty is NICHM Finalist
Gellad Speaks to NYT about Regulation Decisions for Vaccine for Youngest Kids
View All News

Join our mailing list

Stay informed about upcoming CP3 events.

Click here to join our mailing list.

Tweets by @PittCP3View All

 

University of Pittsburgh logo

Center for Pharmaceutical Policy and Prescribing

University of Pittsburgh
Center for Pharmaceutical Policy and Prescribing
310 Scaife Hall
3550 Terrace Street
Pittsburgh, PA 15261

412-624-5198
cp3@pitt.edu

Resources

  • Health Policy Institute
  • Contact Us
  • Student Opportunities
  • Events
  • Pitt Home
  • CP3 on PlumX
Revised 05/16/22Copyright 2022